Drug Profile
Research programme: topical anti-infectives - Helix BioMedix
Alternative Names: HB 1148; HB 1275; HB 153; HB 97; HB-50; Lipohexapeptides - Helix BioMedixLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Helix BioMedix
- Class Biological peptides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Mycoses
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in USA (Topical, Gel)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Mycoses in USA (Topical, Gel)
- 22 Feb 2010 Preclinical development is ongoing in USA